These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17659511)

  • 1. [Heparin versus citrate in the extracorporeal circuitry].
    Vertolli U
    G Ital Nefrol; 2007; 24(4):353; author reply 353-4. PubMed ID: 17659511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulation of extracorporeal circuit in critically ill patients].
    Mariano F; Triolo G
    G Ital Nefrol; 2007; 24(1):34-42. PubMed ID: 17342691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of trisodium citrate and heparin as catheter-locking solution in hemodialysis patients.
    Bevilacqua JL; Gomes JG; Santos VF; Canziani ME
    J Bras Nefrol; 2011 Mar; 33(1):86-92. PubMed ID: 21541468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy.
    Tillman J
    Nurs Crit Care; 2009; 14(4):191-9. PubMed ID: 19531037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heparin and more].
    Triolo G; Mariano F
    G Ital Nefrol; 2008; 25(1):105. PubMed ID: 18264927
    [No Abstract]   [Full Text] [Related]  

  • 6. Dialysis techniques in the critically-ill patient.
    Vanwalleghem J; Maes B; Kuypers D; Messiaen T; Evenepoel P; Vanrenterghem Y
    Acta Clin Belg; 2000; 55(5):237-43. PubMed ID: 11109637
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function.
    Morath C; Miftari N; Dikow R; Hainer C; Zeier M; Morgera S; Weigand MA; Schwenger V
    Nephrol Dial Transplant; 2008 Jan; 23(1):421-2. PubMed ID: 17913732
    [No Abstract]   [Full Text] [Related]  

  • 8. Trisodium citrate 30% vs. heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent haemodialysis.
    Stas KJ; Vanwalleghem J; De Moor B; Keuleers H
    Nephrol Dial Transplant; 2001 Jul; 16(7):1521-2. PubMed ID: 11427666
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of thrombosis in extracorporeal circulation: variations of anticoagulation.
    Toomasian JM; Helmer GA; Zeme MI; Oltean JN; Oran AD; Bartlett RH
    Trans Am Soc Artif Intern Organs; 1983; 29():206-9. PubMed ID: 6673231
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of bacterial contamination from citrate catheter locks.
    Stranz M; Hadaway L
    Semin Dial; 2009; 22(6):704. PubMed ID: 20017844
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticoagulation of extra-corporeal circuits by citrates].
    Verschoore M
    Soins; 2007 Oct; (719 Suppl):S20-1. PubMed ID: 18050873
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional citrate anticoagulation--finally on its way to standardization?
    Joannidis M
    Crit Care Med; 2009 Jun; 37(6):2128-9. PubMed ID: 19448471
    [No Abstract]   [Full Text] [Related]  

  • 13. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation.
    Calatzis A; Toepfer M; Schramm W; Spannagl M; Schiffl H
    Nephron; 2001 Oct; 89(2):233-6. PubMed ID: 11549910
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study.
    Gubensek J; Buturovic-Ponikvar J; Ponikvar R
    Blood Purif; 2007; 25(5-6):454-6. PubMed ID: 18057876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citrate regional anticoagulation in haemodialysis.
    Hocken AG; Hurst PL
    Nephron; 1987; 46(1):7-10. PubMed ID: 3600914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation].
    Matsuda O
    Nihon Rinsho; 1991 Dec; 49 Suppl():279-86. PubMed ID: 1808269
    [No Abstract]   [Full Text] [Related]  

  • 17. Issues with heparin, and the role of citrate.
    Kossmann RJ; Ahmad S
    Nephrol News Issues; 2008 Jun; 22(7):26-7. PubMed ID: 18795451
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulation in continuous veno-venous haemofiltration.
    Brooks G
    Nurs Crit Care; 2000; 5(4):200-4. PubMed ID: 11235418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Selleng S; Greinacher A
    Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.